What is CENX's health score?

CENTURY ALUMINUM CO (CENX) has a TradeApes health score of 66 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CENX's estimated fair value?

Based on our 5-year discounted cash flow model, CENTURY ALUMINUM CO's estimated fair value is $9.44 per share, representing a -85.9% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is CENX undervalued or overvalued?

Our model currently rates CENX as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CENX... Refresh in a moment for the full analysis.

CENTURY ALUMINUM CO (CENX)

Materials Overvalued low healthy

$67.04

Updated: 2026-06-04

TradeApes Score

Financial Strength

85 Strong

Operating Trend

70 Healthy

Relative Value

60 Healthy

Capital Allocation

25 Stressed

Risk

80 Strong

Est. Fair Value $9.44

DCF Upside -85.9%

Sector Rank #430 of 1343

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.